Morphosys stock rated as a sell
Web78.0%. +1.5%. Market Cap. The market value of a company, in total dollars, also called "market capitalization." Market cap is calculated by taking a company's price per share … WebGet the latest Morphosys Ag (MOR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …
Morphosys stock rated as a sell
Did you know?
WebMorphoSys AG analyst ratings, historical stock prices, ... Analyst Ratings MorphoSys AG 3 Months Ago 1 Month Ago Current; Buy: 5. 4. 4. ... Sell Your Business; WebMar 12, 2024 · Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish catastrophic capital loss on anyone. Imagine if you held MorphoSys AG for half a decade as the share price tanked 83%. And some of the more recent buyers are probably worried, too, with the stock falling 39% in the last year.
WebApr 11, 2024 · View MorphoSys AG Unsponsored ADR MOR investment & stock information. Get the latest MorphoSys AG ... Sell: 5.38%: 5: ... Zacks Rank stock … WebJun 2, 2024 · An EZH2 inhibitor from Epizyme won Food and Drug Administration approval last year. Morphosys, which is based in Munich, Germany, will pay for the Constellation acquisition in cash, and expects the deal to close in the third quarter. Measured by equity value, MorphoSys’ offer values Constellation at $1.7 billion.
WebMar 20, 2024 · MorphoSys Stock Performance. NASDAQ MOR opened at $3.81 on Monday. The firm has a market cap of $521.70 million, a price-to-earnings ratio of -2.59 … WebDec 15, 2024 · MorphoSys AG (NASDAQ:MOR – Get Rating) has been assigned an average rating of “Hold” from the six brokerages that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have issued a buy recommendation on the …
WebApr 7, 2024 · Morphosys Ag (ADR)’s trailing 12-month revenue is $303.4 million with a -54.3% profit margin. Year-over-year quarterly sales growth most recently was 54.3%. …
Web12 hours ago · Northern Data produced a total of 217 Bitcoin in March 2024, geneRating revenues of EUR 5.1 million, which was 10% higher than the corresponding figure for the previous month. incident at westminster todayWebApr 5, 2024 · Get Options expert Chris Capre's next two alerts! MOR Price Action: MorphoSys has a 52-week high of $7.48 and a 52-week low of $3.5. MorphoSys … incident at west croydon station todayWebMedigene AG (Medigene, FSE: MDG1, Prime Standard), an early-stage immuno-oncology platform company fo... See more » incident boness road grangemouthWebMorphosys Ag ADR stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction. incident business management handbook 2021Web2 days ago · Open. A Korean EV battery stock that is the top performer on the country’s small-cap index this year just got its first sell rating, sounding a note of caution for retail investors who have been ... inbody fdaWebBy selling 2.48 million H-shares for a consideration of USD 68.78 million, the US company's stake fell from 11.19% to now 10.90%. Share falls significantly. The news about the reduction triggered a sell-off of around 5% in the stock, bringing it down to USD 27.72 on the Nasdaq exchange. incident by counteeWebApr 5, 2024 · What happened. Shares of MorphoSys ( MOR 7.84%) were up more than 16% Wednesday afternoon after the biopharmaceutical company updated the trials … inbody fat analysis